Progressive Chronic Lymphocytic Leukaemia (CLL)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06650 | Ofatumumab | An anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer medications. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB06650 | Ofatumumab | B-lymphocyte antigen CD20 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|